Mouse aminoacylase 3: A metalloenzyme activated by cobalt and nickel

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1794, Issue 7, 2009, Pages 1049-1057

  Tsirulnikov, Kirill ^a   Abuladze, Natalia ^a   Newman, Debra ^a   Ryazantsev, Sergey ^a   Wolak, Talya ^a,b   Magilnick, Nathaniel ^a   Koag, Myong Chul ^a   Kurtz, Ira ^a   Pushkin, Alexander ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Aminoacylase; Cobalt; Metalloprotein; Zinc

Indexed keywords

ALANINE; AMINOACYLASE 3; ARGININE; ASPARAGINE; ASPARTIC ACID; ASPARTOACYLASE; CADMIUM; CALCIUM; COBALT; FERROUS ION; GLUTAMIC ACID; HISTIDINE; MANGANESE; METALLOPROTEIN; MONOMER; NICKEL; POTASSIUM; SODIUM; TYROSINE; UNCLASSIFIED DRUG; ZINC;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CATALYSIS; CELL STRAIN HEK293; CONTROLLED STUDY; DEACETYLATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; METAL BINDING; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; WILD TYPE;

AMIDOHYDROLASES; ANIMALS; CLONING, MOLECULAR; COBALT; ENZYME ACTIVATION; HELA CELLS; HUMANS; MICE; MODELS, MOLECULAR; NICKEL; PROTEIN CONFORMATION;

EID: 67349191604     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2009.03.022     Document Type: Article

References (48)

1. Perrson B., Flinta C., von Heijne G., and Jörnvall H. Structures of N-terminally acetylated proteins. Eur. J. Biochem. 152 (1985) 523-527
2. Driesen H.P.C., De Jong W.W., Tesser G.I., and Bloemendal H. The mechanism of N-terminal acetylation of proteins. Crit. Rev. Biochem. Mol. Biol. 18 (1985) 281-325
3. Anders M.W., and Dekant W. Aminoacylases. Adv. Pharmacol. 27 (1994) 431-448
4. Newman D., Abuladze N., Scholz K., Dekant W., Tsuprun V., Ryazantsev S., Bondar G., Sassani P., Kurtz I., and Pushkin A. Specificity of aminoacylase III-mediated deacetylation of mercapturic acids. Drug Metabol. Disposit. 35 (2007) 43-50
5. Anders M.W., Dekant W., and Vamvakas S. Formation and fate of nephrotoxic and cytotoxic glutathione S-conjugates: cysteine conjugate beta-lyase pathway. Adv. Pharmacol. 27 (1994) 115-162
6. Hayden P.J., and Stevens J.L. Cysteine conjugate toxicity, metabolism and binding to macromolecules in isolated rat kidney mitochondria. Mol. Pharmacol. 37 (1990) 468-476
7. Commandeur J.N.M., Stijntjes G.J., and Vermeulen N.P.E. Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Role of bioactivation and detoxification mechanisms of xenobiotics. Pharmacol. Rev. 47 (1995) 271-330
8. Birner G., Bernauer U., Werner M., and Dekant W. Biotransformation, excretion, and nephrotoxicity of haloalkene-derived cysteine S-conjugates. Arch. Toxicol. 72 (1997) 1-8
9. Boogaard P.J., Commandeur J.N.M., Mulder G.J., Vermeulen N.P.E., and Nagelkerke J.F. Toxicity of the cysteine-S-conjugates and mercapturic acids of four structurally related difluoroethylenes in isolated proximal tubular cells from rat kidney: uptake of the conjugates and activation to toxic metabolites. Biochem. Pharmacol. 38 (1989) 3731-3741
10. Commandeur J.N., Boogaard P.J., Mulder G.J., and Vermeulen N.P. Mutagenicity and cytotoxicity of two regioisomeric mercapturic acids and cysteine S-conjugates of trichloroethylene. Arch. Toxicol. 65 (1991) 373-380
11. Lash L.H., Hueni S.E., and Putt D.A. Apoptosis, necrosis and cell proliferation induced by S-(1,2-dichlorovinyl)-L-cysteine in primary cultures of human proximal tubular cells. Toxicol. Appl. Pharmacol. 177 (2001) 1-16
12. Löffler H.G., Schneider F., Aumuller G., and Unsicker K. Immunocytochemical studies of aminoacylase I (EC 3.5.1.14) localization in the swine kidney. Acta Histochem. Suppl. 25 (1982) 57-60
13. Lindner H., Hopfner S., Tafler-Naumann M., Miko M., Konrad L., and Röhm K.H. The distribution of aminoacylase I among mammalian species and localization of the enzyme in porcine kidney. Biochimie 82 (2000) 129-137
14. Pushkin A., Carpenito G., Abuladze N., Newman D., Tsuprun V., Ryazantsev S., Motemoturu S., Sassani P., Solovieva N., Dukkipati R., and Kurtz I. Structural characterization, tissue distribution, and functional expression of murine aminoacylase III. Am. J. Physiol. 286 (2004) C848-C856
15. Uttamsingh V., Baggs R.B., Krenitsky D.M., and Anders M.W. Immunohistochemical localization of the acylases that catalyze the deacetylation of N-acetyl-L-cysteine and haloalkene-derived mercapturates. Drug Metab. Dispos. 28 (2000) 625-632
16. Matalon R., Michals K., Sebesta D., Deanching M., Gashkoff P., and Casanova J. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. Am. J. Med. Genet. 29 (1988) 463-471
17. Bitto E., Bingman C.A., Wesenberg G.E., McCoy J.G., and Phillips Jr. G.N. Structure of aspartoacylase, the brain enzyme impaired in Canavan disease. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 456-461
18. Le Coq J., An H.J., Lebrilla C., and Viola R.E. Characterization of human aspartoacylase: the brain enzyme responsible for Canavan disease. Biochemistry 45 (2006) 5878-5884
19. Kaul R., Gao G.P., Balamurugan K., and Matalon R. Cloning of the human aspartoacylase cDNA and a common missence mutation in Canavan disease. Nat. Genet. 5 (1993) 118-123
20. Herga S., Berrin J.-G., Perrier J., Puigserver A., A., and Giardina T. Identification of the zinc binding ligands and the catalytic residue in human aspartoacylase, an enzyme involved in Canavan disease. FEBS Lett. 580 (2006) 5899-5904
21. Kördel W., and Schneider F. Chemical investigations on pig kidney aminoacylase. Biochim. Biophys. Acta 445 (1976) 446-457
22. Kördel W., and Schneider F. Renal aminoacylase, a zinc enzyme. Z. Naturforsch. 32C (1977) 342-344
23. Palm C.J., and Röhm K.H. Aminoacylase I from porcine kidney: identification and characterization of two major protein domains. J. Protein Chem. 14 (1995) 233-240
24. Wu H.B., and Tsou C.L. A comparison of Zn(II) and Co(II) in the kinetics of inactivation of aminoacylase by 1,10-phenanthroline and reconstitution of the apoenzyme. Biochem. J. 296 (1993) 435-441
25. 2+-substituted aminoacylase I. Eur. J. Biochem. 188 (1990) 175-180
26. Lindner H.A., Lunin V.V., Alary A., Hecker R., Cygler M., and Menard R. Essential roles of zinc ligation and enzyme dimerization for catalysis in the aminoacylase-1/M20 family. J. Biol. Chem. 278 (2003) 44496-44504
27. Tang Z.Y., Yu J.Y., Zhou Q., He B., Wang Z.F., and Zhou H.M. Secondary structure of holo- and apo-aminoacylase from prediction, circular dichroism, and FT-Raman spectroscopy. J. Biochem. 118 (1995) 706-709
28. Kaul R., Casanova J., Johnson A.B., Tang P., and Matalon R. Purification, characterization, and localization of aspartoacylase from bovine brain. J. Neurochem. 56 (1991) 129-135
29. Udenfriend S., Stein S., Bohlen P., Dairman W., Leimgruber W., and Weigele M. Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science 178 (1972) 871-872
30. Valentine R.C., and Green N.M. Electron microscopy of an antibody-hapten complex. J. Mol. Biol. 27 (1967) 615-617
31. Kopp J., and Schwede T. The SWISS-MODEL Repository of annotated three-dimensional protein structure homology models. Nuc. Acid. Res. 32 (2004) D230-D234
32. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60 (2004) 2126-2132
33. The CCP4 suite: programs for protein crystallography, Acta Crystallogr. D Biol. Crystallogr. 50 (1994) 760-763.
34. Elfarra A.A., Jakobson I., and Anders M.W. Mechanism of S-(1,2-dichlorovinyl)glutathione-induced nephrotoxicity. Biochem. Pharmacol. 35 (1986) 283-288
35. Hershfield J.R., Madhavarao C.N., Moffett J.R., Benjamins J.A., Garbern J.Y., and Narboodiri A. Aspartoacylase is a regulated nuclear-cytoplasmic enzyme. FASEB J. 20 (2006) 2139-2141
36. Le Coq J., Pavlovsky A., Malik R., Sanishvili R., Xu C., and Viola R.E. Examination of the mechanism of human brain aspartoacylase through the binding of an intermediate analogue. Biochemistry 47 (2008) 3484-3492
37. Suzuki S., and Tateishi M. M. Purification and characterization of a rat liver enzyme catalyzing N-deacetylation of mercapturic acid conjugates. Drug Metabol. Disposit. 9 (1981) 573-577
38. Uttamsingh V., and Anders M.W. Acylase-catalyzed deacetylation of haloalkene-derived mercapturates. Chem. Res. Toxicol. 12 (1999) 937-942
39. Endo Y. N-acetyl-aromatic amino acid deacylase in animal tissues. Biochim. Biophys. Acta 523 (1978) 207-214
40. Hershfield J.R., Pattabiraman N., Madhavarao C.N., and Namboodiri M.A.A. Mutational analysis of aspartoacylase: implications for Canavan disease. Brain Res. 1148 (2007) 1-14
41. Ryazantsev S., Abuladze N., Newman D., Bondar G., Kurtz I., and Pushkin A. Structural characterization of dimeric murine aminoacylase III. FEBS Lett. 581 (2007) 1898-1902
42. Boucher E., Bourienne A., Adams P., Turlin B., Brissot P., and Deugnier Y. Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment. Gut 41 (1997) 115-120
43. Cabantchik Z.I., Breuer W., Zaninelli G., and Cianciulli P. LPI-labile iron in iron overload. Best Pract. Res. Clin. Haematol. 18 (2005) 277-287
44. Frieden C. Protein aggregation processes: in search of the mechanism. Protein Sci. 16 (2007) 2334-2344
45. Fändrich M. On the structural definition of amyloid fibrils and other polypeptide aggregates. Cell Mol. Life Sci. 64 (2007) 2066-2078
46. Castagnetto J.M., Hennessy S.W., Roberts V.A., Getzoff E.D., Tainer J.A., and Pique M.E. MDB: the metalloprotein database and Browser at the Scripps research institute. Nucl. Acid. Res. 30 (2002) 379-382
47. Karlin S., Zhu Z.Y., and Karlin K.D. The extended environment of mononuclear metal centers in protein structures. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 14225-14230
48. Heese D., and Röhm K.H. Reactivities of sulfhydryl groups in native and metal-free aminoacylase I. Biol. Chem. Hoppe Seyler. 370 (1989) 607-612